24 hours ago We are the largest patient volume autoimmune disease HSCT private treatment center in the world. Doctor Ruiz Argüelles and Doctor Gómez-Almaguer have performed more than 3,000 … >> Go To The Portal
There are two Clinica Ruiz centres in Mexico: Puebla which has been offering HSCT to MS patients for nearly four years and Monterrey which has been doing the same for nearly one year now. The centres are headed up by pre-eminent haematologists, Dr Ruiz Argüelles in Puebla and Dr. Gómez-Almaguer in Monterrey.
The centres are headed up by pre-eminent haematologists, Dr Ruiz Argüelles in Puebla and Dr. Gómez-Almaguer in Monterrey. Both have worked together for many years dedicating their lives to curing cancer, MS and other blood related diseases and have performed HSCT on hundreds of patients.
About Clinica Ruiz We are the largest patient volume autoimmune disease HSCT private treatment center in the world. Doctor Ruiz Argüelles and Doctor Gómez-Almaguer have performed more than 3,000 HSCT procedures during more than 20 years for hematological and autoimmune diseases, out of which over 900 have been for MS.
Internationally there are really only two ‘commercial’ places with good HSCT track records that have processed MS patients in any number. Either Dr Fedorenko’s clinic in Moscow or Clinica Ruiz in Mexico. There are other centres like the one in Chicago US.
La Medicina Interna se encarga del estudio y del tratamiento de las enfermedades de los adultos; lo médicos internistas son "Doctores para adultos". En el Centro de Hematologia y Medicina Interna se atienden pacientes con diversas enfermedades de la medicina interna: Endocrinológicas, gastrointestinales, pulmonares, infecciosas, cardiovasculares, renales, neurológicas, hematológicas etc., y se llevan a cabo revisiones integrales del estado de salud, también llamadas "chequeos".
La Hematología es una subespecialidad que se encarga del estudio y del tratamiento de las enfermedades de la sangre y de los sitios en donde ésta se produce, principalmente la médula ósea y los ganglios linfáticos. Los hematólogos estudian y tratan a pacientes con anemias, leucemias, linfomas, mielomas, púrpuras, hemofilias, etc.
Es la principal prueba de función pulmonar no invasiva que resulta imprescindible para la evaluación y el seguimiento de las enfermedades respiratorias. Las modalidades de la espirometría son simple y con broncodilatador.
The aim of the entire HSCT treatment process is to stop the immune system from causing damage of the myelin so that proper electrical conduction within the nervous system is restored. In addition to the halting of the underlying autoimmune disease, the reinstatement of appropriate healthy signaling from nerves to muscles often results in clinical and symptomatic improvement.
The aim of the entire HSCT treatment process is to stop the immune system from causing damage of self.
When the cleaning of the immune cells is completed, your hematopoietic stem cell autograft will be retrieved from storage and infused back into your bloodstream. Stem cells have the ability to naturally “home” into your bone marrow and start dividing again in a healthy manner to repopulate your system with new immune cells. This is known as engraftment.
Patients with an Expanded Disability Status Scale (EDSS) up to 7.0 will be accepted for transplantation, pending all other acceptance factors. (If you do not know your EDSS please follow this link to self-evaluate) https://goo.gl/FAAGBh
Patient has to be able to travel to and remain in Puebla, México or Monterrey, Mexico during a 28-day period, accompanied by a caregiver.
Es la principal prueba de función pulmonar no invasiva que resulta imprescindible para la evaluación y el seguimiento de las enfermedades respiratorias. Las modalidades de la espirometría son simple y con broncodilatador.
La Medicina Interna se encarga del estudio y del tratamiento de las enfermedades de los adultos; lo médicos internistas son "Doctores para adultos". En el Centro de Hematologia y Medicina Interna se atienden pacientes con diversas enfermedades de la medicina interna: Endocrinológicas, gastrointestinales, pulmonares, infecciosas, cardiovasculares, renales, neurológicas, hematológicas etc., y se llevan a cabo revisiones integrales del estado de salud, también llamadas "chequeos".
There are two Clinica Ruiz centres in Mexico: Puebla which has been offering HSCT to MS patients for nearly four years and Monterrey which has been doing the same for nearly one year now. The centres are headed up by pre-eminent haematologists, Dr Ruiz Argüelles in Puebla and Dr. Gómez-Almaguer in Monterrey. Both have worked together ...
Very briefly, most HSCT treatments involve four rounds of chemo over four days to get to neutropenia (a state when the body's immune system is effectively knocked out). This is a very traumatic and uncomfortable experience. In Mexico they split the chemo into two batches of two sessions one week apart.
The aim of the entire HSCT treatment process is to stop the immune system from causing damage of the myelin so that proper electrical conduction within the nervous system is restored. In addition to the halting of the underlying autoimmune disease, the reinstatement of appropriate healthy signaling from nerves to muscles often results in clinical and symptomatic improvement.
The aim of the entire HSCT treatment process is to stop the immune system from causing damage of self.
When the cleaning of the immune cells is completed, your hematopoietic stem cell autograft will be retrieved from storage and infused back into your bloodstream. Stem cells have the ability to naturally “home” into your bone marrow and start dividing again in a healthy manner to repopulate your system with new immune cells. This is known as engraftment.
Patients with an Expanded Disability Status Scale (EDSS) up to 7.0 will be accepted for transplantation, pending all other acceptance factors. (If you do not know your EDSS please follow this link to self-evaluate) https://goo.gl/FAAGBh
Patient has to be able to travel to and remain in Puebla, México or Monterrey, Mexico during a 28-day period, accompanied by a caregiver.
Patients must be free of contraindicating health factors as determined by the clinic HSCT physician, and be deemed suitably healthy to safely tolerate the treatment. Patients should be able to self-transfer from one seated position to another, with the assistance of a caregiver.
HSCT (also known as BMT, AHSCT or simply ASCT) stands for Haematopoietic Stem Cell Transplant. HSCT should not be confused with ‘Stem Cell Therapy’ or ‘Stem Cell Treatment’. HSCT has been used to treat MS for over 20 years now. Moreover, it was already a well-established treatment, having been performed 2 million times since 1959, when the first ever bone marrow transplant took place. It is currently performed over 50,000 times every year for cancer, and more than 3,000 patients have had HSCT for MS to date.
Prospective HSCT patients often ask what is the process of stem cell transplant? HSCT is a procedure that works by ablating the faulty T and B lymphocyte cells that work to damage the immune system in MS and other haematologically rooted autoimmune conditions. This ablation is achieved with chemotherapy; it is important to note that stem cells alone will not achieve the desired result. When the faulty immune system and the T and B lymphocytes have been wiped out with chemotherapy, naïve stem cells are re-infused into the body. These cells have no memory of MS and are harvested from the patient prior to the immune system’s being wiped out with chemotherapy. The stem cells work to help rebuild a new, functional immune system for the patient – one that is no longer attacking itself. The aim of HSCT is to halt progression, but many patients see symptomatic improvements too.
People are often concerned about the time it takes to recover from HSCT, and recovery time can vary, but the patient is usually well enough to leave the hospital within two or three weeks of the transplant. On discharge from hospital, some patients choose to follow a neutropenic diet for up to six months, and various precautions should be taken in terms of hygiene and avoiding infection – the most important of these being frequent handwashing. AIMS has known people return to work in as little as 2-3 months, but recovery will be different for everyone.
As with any medical procedure, there is an element of risk, and HSCT is a chemotherapy which does carry its own risks. However, to be accepted for HSCT, the patient will undergo several rigorous medical checks to ensure that they are suitable for the procedure – this is the case at all HSCT hospitals AIMS supports. HSCT does come with a mortality risk, but this risk varies significantly depending on the type of HSCT used (Myelo, which completely ablates the immune system, or Non-Myelo which ablates most of it – Non-Myelo is used in the UK and at the international hospitals AIMS supports), the drug regimen being used and the condition being treated. Underlying health issues may also cause complications, but Dr Richard K Burt recently stated that the risk of Non-Myelo HSCT for MS is around 0.3%
Warrior: Jan-Marie AI: Multiple Sclerosis HSCT: June 16, 2020 Superpower: Hope
Warrior: Jan-Marie Morgan AI: Multiple Sclerosis HSCT: June, 2020 Superpower: Patience
Warrior: Craig Witkowski AI: Multiple Sclerosis HSCT: September 2019 in Puebla Superpower: Patience
Warrior: Leta Krieger Snowflake: Secondary Progressive Multiple Sclerosis HSCT: 07-08/18 Superpower: Support from husband and friends